PT  - JOURNAL ARTICLE
AU  - Gautham Appanna
AU  - Yiannis Kallis
TI  - An update on the management of cholestatic liver diseases
AID  - 10.7861/clinmed.2020-0697
DP  - 2020 Sep 01
TA  - Clinical Medicine
PG  - 513--516
VI  - 20
IP  - 5
4099  - http://www.rcpjournals.org/content/20/5/513.short
4100  - http://www.rcpjournals.org/content/20/5/513.full
SO  - Clin Med2020 Sep 01; 20
AB  - Cholestatic liver diseases are a challenging spectrum of conditions arising from damage to bile ducts, leading to build-up of bile acids and inflammatory processes that cause injury to cholangiocytes and hepatocytes. Primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC) are the two most common cholestatic disorders. In this review we detail the latest guidelines for the diagnosis and management of patients with these two conditions.